| Primary |
| Vitamin B12 Deficiency |
32.7% |
| Diabetic Nephropathy |
11.5% |
| Product Used For Unknown Indication |
11.5% |
| Supplementation Therapy |
11.5% |
| Pernicious Anaemia |
5.8% |
| Asthenia |
3.8% |
| Drug Use For Unknown Indication |
3.8% |
| Neuropathy Peripheral |
3.8% |
| Vitamin B12 Decreased |
3.8% |
| Coeliac Disease |
1.9% |
| Hypoaesthesia |
1.9% |
| Intestinal Resection |
1.9% |
| Psychotic Disorder |
1.9% |
| Red Blood Cell Count |
1.9% |
| Vitamin B12 |
1.9% |
|
| Tremor |
20.6% |
| Asthenia |
5.9% |
| Drug Hypersensitivity |
5.9% |
| Glomerular Filtration Rate Decreased |
5.9% |
| Oropharyngeal Pain |
5.9% |
| Product Quality Issue |
5.9% |
| Reaction To Preservatives |
5.9% |
| Unevaluable Event |
5.9% |
| Urticaria |
5.9% |
| Acute Hepatic Failure |
2.9% |
| Agitation |
2.9% |
| Aortic Dissection |
2.9% |
| Burning Sensation |
2.9% |
| Condition Aggravated |
2.9% |
| Conjunctivitis |
2.9% |
| Diarrhoea |
2.9% |
| Dysphagia |
2.9% |
| Dyspnoea |
2.9% |
| Eye Swelling |
2.9% |
| Feeling Abnormal |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.1% |
| Product Used For Unknown Indication |
17.3% |
| Hypertension |
7.8% |
| Hyperlipidaemia |
3.6% |
| Non-small Cell Lung Cancer |
3.6% |
| Pain |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Depression |
3.0% |
| Infection |
3.0% |
| Neuropathy Peripheral |
3.0% |
| Gastritis |
2.7% |
| Herpes Zoster |
2.7% |
| B-cell Lymphoma |
2.4% |
| Pulmonary Hypertension |
2.4% |
| Constipation |
2.1% |
| Insomnia |
2.1% |
| Bone Neoplasm Malignant |
1.8% |
| Coronary Artery Disease |
1.8% |
| Diabetic Nephropathy |
1.8% |
| Drug Eruption |
1.8% |
|
| Completed Suicide |
9.8% |
| Sepsis |
9.8% |
| Tinnitus |
9.8% |
| Liver Disorder |
6.6% |
| White Blood Cell Count Decreased |
6.6% |
| Medication Error |
4.9% |
| Nausea |
4.9% |
| Osteomyelitis |
4.9% |
| Toxic Epidermal Necrolysis |
4.9% |
| Vomiting |
4.9% |
| Cerebral Haemorrhage |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Dyspnoea |
3.3% |
| Eosinophilia |
3.3% |
| Glomerular Filtration Rate Decreased |
3.3% |
| Hepatitis Acute |
3.3% |
| Interstitial Lung Disease |
3.3% |
| Platelet Count Decreased |
3.3% |
| Respiratory Arrest |
3.3% |
| Scoliosis |
3.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.7% |
| Product Used For Unknown Indication |
19.7% |
| Hypertension |
8.2% |
| Prophylaxis |
6.8% |
| Rheumatoid Arthritis |
6.5% |
| Pain |
4.4% |
| Crohn's Disease |
4.3% |
| Osteoporosis |
4.2% |
| Diabetes Mellitus |
2.9% |
| Insomnia |
2.6% |
| Constipation |
2.6% |
| Pleural Mesothelioma Malignant |
2.3% |
| Multiple Myeloma |
2.0% |
| Depression |
1.8% |
| Anaemia |
1.8% |
| Herpes Zoster |
1.8% |
| Vitamin Supplementation |
1.7% |
| Gastritis |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
|
| Vomiting |
11.5% |
| White Blood Cell Count Decreased |
10.5% |
| Weight Decreased |
6.2% |
| Thrombocytopenia |
5.5% |
| Urinary Tract Infection |
5.5% |
| Pyrexia |
5.3% |
| Renal Impairment |
5.3% |
| Pneumonia |
5.1% |
| Renal Failure Acute |
5.1% |
| Weight Increased |
4.6% |
| Death |
4.4% |
| White Blood Cell Count Increased |
4.4% |
| Rash |
3.9% |
| Nausea |
3.5% |
| Somnolence |
3.5% |
| Fatigue |
3.4% |
| Pain |
3.4% |
| Interstitial Lung Disease |
3.2% |
| Sepsis |
3.2% |
| Tremor |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
41.7% |
| Anxiety |
8.3% |
| Depression |
8.3% |
| Hypertension |
8.3% |
| Stress |
8.3% |
| Arthritis |
4.2% |
| Asthenia |
4.2% |
| Fibromyalgia |
4.2% |
| Hypertonic Bladder |
4.2% |
| Neuropathy Peripheral |
4.2% |
| Vitamin Supplementation |
4.2% |
|
| Drug Interaction |
50.0% |
| Diarrhoea |
25.0% |
| Uterine Cancer |
25.0% |
|
